Prevention & lipidsCohort study

The differential impact of abdominal obesity on fasting and non-fasting triglycerides and cardiovascular risk

Eur J Prev CardiolPublished

  • Cohort study
  • UK Biobank
  • polygenic score

Authors' conclusion

Polygenic score for abdominal obesity has a stronger effect on non-fasting than fasting TG levels, reflecting impaired postprandial lipid metabolism.

Study context

Population
UK Biobank participants with random TG levels and self-reported fasting duration
Participants
352,782 participants
Outcome
Interaction of abdominal obesity (WHRadjBMI phenotype and polygenic score) with fasting duration on TG levels, and implications for CVD risk (MI and stroke incidence)

Main finding

As reported in the abstract

Effect of WHRadjBMI on TG levels modified by fasting duration

Interaction with fasting duration, waist-hip ratio adjusted for BMI (WHRadjBMI) phenotype

PInteraction= 6.5x10-32

Interaction with fasting duration, WHRadjBMI polygenic score

PInteraction=0.034

Polygenic score increased non-fasting TG more than fasting TG per SD increase in WHRadjBMI

0.1 mmol/L

Observational data: associations, not effects.

Further findings

Cardiovascular disease (CVD) risk by TG levels

Higher TG levels, regardless of fasting status, associated with higher CVD risk

Association of WHRadjBMI polygenic score with CVD risk, adjusted for TG

Attenuation after adjusting for non-fasting TG (HR=1.41 to HR=1.30)
27%
Attenuation after adjusting for fasting TG (HR=1.38 to HR=1.34)
11%

Original publication

The differential impact of abdominal obesity on fasting and non-fasting triglycerides and cardiovascular risk. Eur J Prev Cardiol. Published 17 February 2025. doi:10.1093/eurjpc/zwaf058

Summarised from the published abstract; every number is checked against it